Browse by author
Lookup NU author(s): Dr Marie Boyle, Dr Steven MassonORCiD, Professor Quentin AnsteeORCiD
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND).
© 2017. Current medical practice artificially dichotomises a diagnosis of fatty liver disease into one of two common forms: alcoholic liver disease (ALD) and non-alcoholic fatty liver disease (NAFLD). Together, these account for the majority of chronic liver diseases worldwide. In recent years, there has been a dramatic increase in the prevalence of obesity and metabolic syndrome within the general population. These factors now coexist with alcohol consumption in a substantial proportion of the population. Each exposure sensitises the liver to the injurious effects of the other; an interaction that drives and potentially accelerates the genesis of liver disease. We review the epidemiological evidence and scientific literature that considers how alcohol consumption interacts with components of the metabolic syndrome to exert synergistic or super-additive effects on the development and progression of liver disease, before discussing how these interactions may be addressed in clinical practice.
Author(s): Boyle M, Masson S, Anstee QM
Publication type: Article
Publication status: Published
Journal: Journal of Hepatology
Year: 2018
Volume: 68
Issue: 2
Pages: 251-267
Print publication date: 01/02/2018
Online publication date: 04/11/2017
Acceptance date: 01/11/2017
Date deposited: 21/12/2017
ISSN (print): 0168-8278
ISSN (electronic): 1600-0641
Publisher: Elsevier BV
URL: https://doi.org/10.1016/j.jhep.2017.11.006
DOI: 10.1016/j.jhep.2017.11.006
Altmetrics provided by Altmetric